Aphria Inc (NYSE: APHA) Q1 2021 earnings call dated Jul. 28, 2021. Corporate Participants: Berrin Noorata -- Chief Corporate Affairs Officer Irwin D.
Aphria Inc (APHA) Q1 2021 Earnings Call Transcript
Aphria Inc (NYSE: APHA) Q1 2021 earnings call dated Jul. 28, 2021. Corporate Participants: Berrin Noorata -- Chief Corporate Affairs Officer Irwin D.
Teva Pharmaceutical Industries Ltd (NYSE: TEVA) Q2 2021 earnings call dated Jul. 28, 2021. Corporate Participants: Kevin C. Mannix -- Senior Vice President,
Humana Inc. (NYSE: HUM) Q2 2021 earnings call dated Jul. 28, 2021 Corporate Participants: Amy Smith -- Vice President of Investor Relations Bruce D.
Pfizer Inc. (NYSE: PFE) Q2 2021 Earnings call dated Jul. 28, 2021 Corporate Participants: Christopher Stevo — Senior Vice President, Chief Investor Relations Officer Albert
Pfizer Inc. (NYSE: PFE) reported second quarter 2021 earnings results today. Total revenue increased 92% year-over-year to $19 billion. GAAP net income
Boston Scientific Corp. (NYSE: BSX) Q2 2021 earnings call dated Jul. 27, 2021 Corporate Participants: Lauren Tengler -- Investor Relations Michael F. Mahoney -- Chairman and
General Electric (NYSE: GE) reported second-quarter 2021 financial results before the regular market hours on Tuesday. The payment services firm reported Q2
TRxADE HEALTH, Inc. (NASDAQ: MEDS) Q2 2021 earnings call dated Jul. 26, 2021 Corporate Participants: Howard Doss -- Chief Financial Officer Suren Ajjarapu -- Chief Executive
After tech start-ups, the biotechnology industry is keeping the IPO market busy nowadays. It is estimated that Wall Street is headed for
PetMed Express, Inc. (NASDAQ: PETS) earnings call dated Jul. 26, 2021 Corporate Participants: Bruce S. Rosenbloom -- Chief Financial Officer Gian M. Fulgoni -- Chairman of Board
Biogen Inc. (NASDAQ: BIIB) Q2 2021 earnings call dated Jul. 22, 2021 Corporate Participants: Mike Hencke -- Director of Investor Relations Michel Vounatsos -- Chief Executive
Novartis AG (NYSE: NVS) Q2 2021 earnings call dated Jul. 21, 2021 Corporate Participants: Samir Shah -- Global Head of Investor Relations
Abbott Laboratories (NYSE: ABT) Q2 2021 earnings call dated Jul. 22, 2021 Corporate Participants: Scott Leinenweber -- Vice President of Investor Relations, Licensing and
Abbott Laboratories (NYSE: ABT) reported second-quarter 2021 financial results before the regular market hours on Thursday. The pharmaceutical giant reported Q2 sales
Biotechnology firm Biogen Inc. (NASDAQ: BIIB) Thursday said its second-quarter earnings and revenues decreased from last year. The results, however, came in
Intuitive Surgical Inc (NASDAQ: ISRG) Q2 2021 earnings call dated Jul. 20, 2021 Corporate Participants: Calvin Darling -- Senior Director of Finance,
Johnson & Johnson (NYSE: JNJ) Q2 2021 earnings call dated Jul. 21, 2021 Corporate Participants: Christopher DelOrefice -- Vice President, Investor Relations Joseph J.
Johnson & Johnson (NYSE: JNJ) Q2 2021 earnings call dated Jul. 21, 2021 Corporate Participants: Christopher DelOrefice — Vice President, Investor Relations Joseph J. Wolk — Executive
Healthcare Services Group, Inc. (NASDAQ: HCSG) Q2 2021 earnings call dated Jul. 21, 2021 Corporate Participants: Ted Wahl -- President and Chief Executive Officer
Anthem Inc (NYSE: ANTM) Q2 2021 Earnings call dated Jul. 21, 2021 Corporate Participants: Stephen Tanal -- Vice President of Investor Relations Gail K.
Johnson & Johnson (NYSE: JNJ) reported second-quarter 2021 financial results before the regular market hours on Wednesday. The pharmaceutical giant reported Q2